Standout Papers

A Long-Acting FGF21 Molecule, PF-05231023, Decreases Body Weight and Improves Lipid Profile in Non-hu... 2016 2026 2019 2022 398
  1. A Long-Acting FGF21 Molecule, PF-05231023, Decreases Body Weight and Improves Lipid Profile in Non-human Primates and Type 2 Diabetic Subjects (2016)
    Saswata Talukdar, Yingjiang Zhou et al. Cell Metabolism

Immediate Impact

37 from Science/Nature 80 standout
Sub-graph 1 of 19

Citing Papers

Refining the impact of genetic evidence on clinical success
2024 StandoutNature
Acquisition of epithelial plasticity in human chronic liver disease
2024 StandoutNature
23 intermediate papers

Works of Yingjiang Zhou being referenced

XBP1s Is an Anti-lipogenic Protein
2016
A Long-Acting FGF21 Molecule, PF-05231023, Decreases Body Weight and Improves Lipid Profile in Non-human Primates and Type 2 Diabetic Subjects
2016 Standout
and 11 more

Author Peers

Author Last Decade Papers Cites
Yingjiang Zhou 1374 859 698 32 2.8k
Giovanni Solinas 1716 1212 1335 45 3.9k
Ana Paula Arruda 973 638 869 38 2.3k
Feifan Guo 1136 477 647 53 2.3k
Jiro Hirosumi 1709 1400 1312 29 3.7k
Yongsheng Chang 1828 753 994 89 3.5k
Thierry Grémeaux 1794 817 1063 39 3.0k
Hai‐Bin Ruan 1907 603 986 51 3.2k
Yingfeng Deng 1108 790 756 43 2.5k
Françoise Assimacopoulos‐Jeannet 772 475 1065 28 2.2k
Jianying Dong 1543 808 1193 25 3.1k

All Works

Loading papers...

Rankless by CCL
2026